Aethlon Medical, Inc. (AEMD) Stock Skyrockets Following Success of Hemopurifier Treatment in Covid-19 Patient
Aethlon Medical, Inc. (AEMD) stock prices were up by a marginal 0.45% as of the market closing on June 8th, 2021, bringing the price per share up to USD$2.21 at the end of the trading day. After-hours trading saw the stock skyrocket by an astounding 92.31%, bringing it up to USDS$4.25. EUA for Hemopurifier The […]
Vaxart, Inc. (VXRT) Stock Trending Higher Following Enrollment of First Patient in Norovirus Clinical Trial
Vaxart, Inc. (VXRT) stock prices were up by 6.84% as of the market closing on June 7th, 2021, bringing the price per share up to USD$7.34 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by 4.22%, bringing it up to USD$7.65. Get the hottest stocks to trade every […]
Adamis Pharmaceuticals Corp. (ADMP) Stock Surges Following Promising News of TEMPOL as Potential Covid-19 Treatment
AdamisPharmaceuticals Corp. (ADMP) stock prices were up by a significant 17.84% shortly after market trading commenced on June 7th, 2021, bringing the price per share up to USD$1.1784 early on in the trading day. TEMPOL The company announced on June 7th, 2021 that the National Institute of Health (NIH) had identified the company’s proprietary experimental […]
Jiuzi Holdings, Inc. (JZXN) Stock Surges Shortly After its Initial Public Offering Closes
Jiuzi Holdings, Inc. (JZXN) stock prices were up by a promising 23.85% as of the market opening on May 21st, 2021, bringing the price per share up to $0.19 shortly after the trading day commenced. Closing of IPO The company announced on May 20th, 2021 the closing of its initial public offering (IPO) of common […]
Oragenics, Inc. (OGEN) Stock Undergoes Volatility Following Changes in Management and Board of Directors
Oragenics, Inc. (OGEN) stock prices were up by 3.32% as of the market closing on April 14th, 2021, bringing the price per share up to USD$0.6199 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock jump by 1.64%, bringing it up to USD$0.62. Net Loss Reports March 3rd, 2021 saw […]
Cocrystal Pharma, Inc. (COCP) Stock Skyrocketed Following Promising Updates on Covid-19 Drug Development
Cocrystal Pharma, Inc. (COCP) stock prices were up by a monumental 72.58% as of the market closing on may 4th 2021, bringing the price per share up to USD$2.14 at the end of the trading day. Subsequent pre-market fluctuations saw the stock fall by a significant 22.9%, bringing it down to USD$1.65. Covid-19 Treatment Program […]
Vaxart, Inc. (VXRT) Stock Prices Skyrocket Following Announcement of T-cell Webinar
Vaxart, Inc. (VXRT) stock prices were up a staggering 37.46% as of market close on April 27th, 2021, bringing the price per share up to USD$8.33. Novel COVID-19 Tablet With the world hurtling towards COVID-19 solutions for the pandemic, VXRT is setting itself apart from its competitors with a drug, VXA-CoV2-1, that comes in tablet […]
Check out the Sunshine Biopharma, Inc. (OTC PINK:SBFM) latest news and developments
Sunshine Biopharma Inc. (OTC PINK: SBFM), the stock slipped -3.59% to $0.2420 at the previous close. Stocks last month’s performance was recorded 868.00% versus 3-month Performance of 1 628.57%.In the previous trading session Company’s $6.76M. Get the hottest stocks to trade every day before the market opens 100% free. Click here now. SBFMCorporate Focus Besides […]
Providence Therapeutics wins upbeat agreement with the Manitoba Regulators to supply two million doses of COVID-19 vaccines
Corporate Profile Providence Therapeutics is Canada’s leading mRNA vaccine company, with operations in Calgary, Alberta, and Toronto, Ontario. Providence Therapeutics has focused its resources on constructing a world-class COVID-19 vaccine ever since a worldwide COVID-19 vaccine need was identified. Get the hottest stocks to trade every day before the market opens 100% free. Click here […]
Belgium to Obtain Partial Delivery of Pfizer vaccine As Germany tightened the Lockdown
A logistical problem that arose last month meant that Belgium would obtain only half of the doses of vaccine it requested for January from the pharmaceutical company Pfizer. A spokesman for the Health Ministry, Yves Van Laethem, reported that logistical issues in the second half of December prevented the supply of Covid vaccines as expected […]
